Pharmoptima

4717 Campus Drive
Kalamazoo, MI 49008
http://pharmoptima.com
18 Employees

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $886K
First Award Date 06/06/05
Most Recent Award Date 04/19/07

Key Personnel

Last Name Name Awards Contact
Buxser Dr. Stephen Buxser 2 Message

2 Awards Won

Phase 2 SBIR

Agency: Office of the Secretary of Defense
Topic: OSD04-H19
Budget: 04/19/07 - 02/04/08

Finding new antibiotics to treat infections caused by Pseudomonas aeruginosa is a compelling medical need, since the inherently antibiotic resistant nature of the bacteria is being enhanced by the increasing appearance of strains resistant to all currently-marketed antibiotics. Lipopolysaccharide (LPS) is a required and constitutive component o...

Phase 1 SBIR

Agency: Office of the Secretary of Defense
Topic: OSD04-H19
Budget: 06/06/05 - 06/06/06

The outer membrane of Pseudomonas aeuruginosa is more impermeable than that of most other Gram-negative bacteria, contributing significantly to antibiotic resistance. A major component of the outer membrane is lipopolysaccharide (LPS), and understanding its synthesis suggests new targets for antibiotics. WaaP is a kinase responsible for phospho...